ERBB2 and breast carcinoma: Furthermore, given the known racial and ethnic disparities in breast cancer prognosis, it is important to describe the epidemiological characteristics of ERBB2-low breast cancer to understand the potential association with novel antibody-drug conjugates such as T-DXd on breast cancer disparities.